Publication: 2088

Publication: 2088

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: NPJ Breast Cancer vol 2 15023

Year:: 2016
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:: 849 is parent abstract

Methodological:: No
Biospecimen:: Yes
SDC:: Yes
Book Volume:: 5

Parents:: 849
Children:: None

Program:: TRP
Primary Committee:: Correl Sci NOS
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, N01 CA032102, U10 CA021115, U10 CA031946, U10 CA033601, U10 CA180821, U01 CA114722, U10 CA032102, U10 CA180882, U24 CA196171, U24 CA114736, U10 CA025224

Corr. Author:
Authors:: Minetta C Liu Brandelyn N Pitcher Elaine R Mardis Sherri R Davies Paula N Friedman Jacqueline E Snider Tammi L Vickery Jerry P Reed Katherine DeSchryver Baljit Singh William J Gradishar Edith A Perez Silvana Martino Marc L Citron Larry Norton Eric P Winer Clifford A Hudis Lisa A Carey Philip S Bernard Torsten O Nielsen Charles M Perou Matthew J Ellis William T Barry

Networks:: LAPS-CT018, LAPS-IL036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016, NORTHWELL, OZARKS, PR028, TX041

Study: CALGB-159905
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-9741
Phases:: N/A, 3

Keywords:: Article